Sun Pharmaceuticals Industries consolidated net profit rises 40.20% in the June 2024 quarter
Net profit of Sun Pharmaceuticals Industries rose 40.20% to Rs 2835.62 crore in the quarter ended June 2024 as against Rs 2022.54 crore during the previous quarter ended June 2023. Sales rose 6.27% to Rs 12524.51 crore in the quarter ended June 2024 as against Rs 11785.15 crore during the previous quarter ended June 2023.
Particulars | Quarter Ended | ||
Jun. 2024 | Jun. 2023 | % Var. | |
Sales | 12524.51 | 11785.15 | 6 |
OPM % | 28.80 | 28.27 | - |
PBDT | 4078.63 | 3455.33 | 18 |
PBT | 3423.50 | 2804.01 | 22 |
NP | 2835.62 | 2022.54 | 40 |
Low Price Shares
0 mins read . Dec 18, 2024
Nifty 50 Top 10 Stocks
0 mins read . Dec 18, 2024
Best Stocks in 2025
0 mins read . Dec 18, 2024
Explore our products
₹0 Brokerage *
Open Demat Account